Methylphenidate Sandoz Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Full Prescribing Info

Adverse Reactions

Table 2 shows all adverse drug reactions (ADRs) observed during clinical trials and post-market spontaneous reports with Methylphenidate Prolonged-release tablets and those, which have been reported with other methylphenidate hydrochloride formulations. If the ADRs with Methylphenidate Prolonged-release tablets and the methylphenidate formulation frequencies were different, the highest frequency of both databases was used.
Frequency estimate: Very common (≥1/10); common (≥1/100 to < 1/10); uncommon (≥1/1000 to < 1/100); rare (≥1/10,000 to <1/1000); very rare (<1/10,000); not known (cannot be estimated from the available data). (See Table 2.)

Click on icon to see table/diagram/image

*see Precautions.
Adverse drug reactions from spontaneous reports and literature (frequency not known).
Reproductive system and breast disorders: Priapism.

View ADR Reporting Link

Methylphenidate Sandoz Adverse Reactions

methylphenidate

Manufacturer:

Sandoz

Distributor:

Zuellig Pharma